Skip to main content

and
  1. Article

    Open Access

    Correction: Comparison of the clinical characteristics of SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) infected patients from a single hospitalist service

    N. Radhakrishnan, M. Liu, B. Idowu, A. Bansari, K. Rathi in BMC Infectious Diseases (2023)

  2. Article

    Open Access

    Comparison of the clinical characteristics of SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) infected patients from a single hospitalist service

    While existing evidence suggests less severe clinical manifestations and lower mortality are associated with the Omicron variant as compared to the Delta variant. However, these studies fail to control for dif...

    N. Radhakrishnan, M. Liu, B. Idowu, A. Bansari, K. Rathi in BMC Infectious Diseases (2023)

  3. No Access

    Article

    Sequential FOLFOX-6 and gemcitabine for locally advanced and/or metastatic pancreatic cancer

    This prospective phase II trial aims to evaluate the sequential FOLFOX-6 and gemcitabine followed by adapted maintenance for advanced pancreatic cancer. Treatment included FOLFOX-6 for 4 cycles, followed seque...

    M. Ghosn, A. Saroufim, J. Kattan, G. Chahine, F. Nasr, F. Farhat in Medical Oncology (2012)